| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -39,594 | 100% | $3.90 | -$154,377 |
| Net | -1 | -39,594 | -100% | -$154,377 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Cosmo Feilding-Mellen | Director | $29,879,581 | -$154,377 | -0.51% | 02 Jan 2026 |
| Anne Nagengast Johnson | Chief Financial Officer | 30 Jan 2026 | |||
| Gerd Kochendoerfer | Chief Operating Officer | 30 Jan 2026 | |||
| Srinivas Rao | Co-Founder and Chief Executive Officer; Exhibit 24 - Power of Attorney. | 30 Jan 2026 | |||
| Kevin James Craig | Chief Medical Officer | 30 Jan 2026 | |||
| Christopher Ryan Cave Barrett | Chief Legal and Business Officer Exhibit 24 - Power of Attorney. | 30 Jan 2026 | |||
| Glenn Frank Short | Chief Scientific Officer | 30 Jan 2026 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Christopher Ryan Cave Barrett | Restricted Stock Units | Award | 150,000 | 150,000 | 30 Jan 2026 | Direct | ||||
| Christopher Ryan Cave Barrett | Stock Option | Award | 675,000 | 675,000 | 30 Jan 2026 | Direct | ||||
| Kevin James Craig | Restricted Stock Units | Award | 150,000 | 150,000 | 30 Jan 2026 | Direct | ||||
| Kevin James Craig | Stock Option | Award | 675,000 | 675,000 | 30 Jan 2026 | Direct | ||||
| Glenn Frank Short | Restricted Stock Units | Award | 150,000 | 150,000 | 30 Jan 2026 | Direct | ||||
| Glenn Frank Short | Stock Option | Award | 675,000 | 675,000 | 30 Jan 2026 | Direct | ||||
| Gerd Kochendoerfer | Restricted Stock Units | Award | 150,000 | 150,000 | 30 Jan 2026 | Direct | ||||
| Gerd Kochendoerfer | Stock Option | Award | 675,000 | 675,000 | 30 Jan 2026 | Direct | ||||
| Anne Nagengast Johnson | Restricted Stock Units | Award | 117,000 | 117,000 | 30 Jan 2026 | Direct | ||||
| Anne Nagengast Johnson | Stock Option | Award | 525,000 | 525,000 | 30 Jan 2026 | Direct | ||||
| Srinivas Rao | Restricted Stock Units | Award | 442,000 | 442,000 | 30 Jan 2026 | Direct | ||||
| Srinivas Rao | Stock Option | Award | 1,988,000 | 1,988,000 | 30 Jan 2026 | Direct | ||||
| Cosmo Feilding-Mellen | Common Stock | Sale | -0.51% | $154,377 | $3.90 | -39,594 | 7,663,396 | 02 Jan 2026 | Direct |